ADIPOQ and chronic kidney disease: Previous studies showed that patients with CKD exhibited higher serum adiponectin due to impaired urinary adiponectin excretion, while they had a higher incidence of vascular calcification due to higher serum calcium × phosphate products, making the relationship between serum adiponectin and AAC significant and positive.